HRP20080394T3 - Peroral solid dosage form for contraception comprising dienogest and ethinylestradiol - Google Patents
Peroral solid dosage form for contraception comprising dienogest and ethinylestradiolInfo
- Publication number
- HRP20080394T3 HRP20080394T3 HR20080394T HRP20080394T HRP20080394T3 HR P20080394 T3 HRP20080394 T3 HR P20080394T3 HR 20080394 T HR20080394 T HR 20080394T HR P20080394 T HRP20080394 T HR P20080394T HR P20080394 T3 HRP20080394 T3 HR P20080394T3
- Authority
- HR
- Croatia
- Prior art keywords
- dienogest
- ethinylestradiol
- contraception
- dosage form
- solid dosage
- Prior art date
Links
- 229940007694 dienogest and ethinylestradiol Drugs 0.000 title 1
- 239000007909 solid dosage form Substances 0.000 title 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 3
- AZFLJNIPTRTECV-FUMNGEBKSA-N dienogest Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@](CC3)(O)CC#N)CC3)C3=C21 AZFLJNIPTRTECV-FUMNGEBKSA-N 0.000 abstract 3
- 229960003309 dienogest Drugs 0.000 abstract 3
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 2
- 229960002568 ethinylestradiol Drugs 0.000 abstract 2
- 239000003433 contraceptive agent Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Abstract
Disclosed is a solid peroral contraceptive drug containing 17a-cyanomethyI-17-ß-hydroxyestra-4,9-dien-3on (dienogest) at a daily dose that is equal to or smaller than 2.0 mg as one active component and 17a-ethinyl estradiol (ethinyl estradiol) at a daily dose of less than 0.03 mg as another active component along with one or several pharmaceutically acceptable carriers. The dienogest is proportionately released in at least two phases while the ethinyl estradiol is released at the same time as the first phase of the dienogest.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05003179A EP1690543A1 (en) | 2005-02-15 | 2005-02-15 | Pharmaceutical composition for contraception |
EP05003181A EP1690529A1 (en) | 2005-02-15 | 2005-02-15 | Peroral solid dosage form for contraception comprising Dienogest and Ethinylestradiol |
PCT/EP2006/001358 WO2006087177A2 (en) | 2005-02-15 | 2006-02-15 | Solid peroral contraceptive drug |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20080394T3 true HRP20080394T3 (en) | 2008-11-30 |
Family
ID=37951746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20080394T HRP20080394T3 (en) | 2005-02-15 | 2008-08-13 | Peroral solid dosage form for contraception comprising dienogest and ethinylestradiol |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1848406B1 (en) |
JP (1) | JP2008527019A (en) |
KR (1) | KR20070087141A (en) |
AT (1) | ATE395047T1 (en) |
AU (1) | AU2006215822B2 (en) |
BR (1) | BRPI0606297A2 (en) |
CA (1) | CA2594939A1 (en) |
CY (1) | CY1108265T1 (en) |
DE (1) | DE502006000771D1 (en) |
DK (1) | DK1848406T3 (en) |
EA (1) | EA200701389A1 (en) |
ES (1) | ES2310907T3 (en) |
HR (1) | HRP20080394T3 (en) |
IL (1) | IL184257A0 (en) |
NO (1) | NO20072893L (en) |
PL (1) | PL1848406T3 (en) |
PT (1) | PT1848406E (en) |
RS (1) | RS50597B (en) |
SI (1) | SI1848406T1 (en) |
WO (1) | WO2006087177A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2681021A1 (en) * | 2007-07-31 | 2009-02-05 | Bayer Schering Pharma Aktiengesellschaft | Single-phase pharmaceutical composite preparation (dienogest and ethinyl estradiol) for oral therapy for regulation of blood pressure |
EP2170347A1 (en) * | 2007-07-31 | 2010-04-07 | Bayer Schering Pharma Aktiengesellschaft | Single-phase pharmaceutical composite preparation (dienogest and ethinyl estradiol) for oral therapy for regulation of blood pressure |
JP6759478B2 (en) * | 2019-02-13 | 2020-09-23 | 富士製薬工業株式会社 | Oral solid composition, a method for producing the same, and an oral tablet obtained by the method for producing the oral solid composition. |
EP3954364A1 (en) | 2020-08-14 | 2022-02-16 | Chemo Research, S.L. | New modified release oral contraceptive composition |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19525017A1 (en) * | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmaceutical combination preparation, kit and method for hormonal contraception |
ES2223081T3 (en) * | 1996-07-26 | 2005-02-16 | Wyeth | MONOFASTIC ORAL ANTICONCEPTIVE METHOD AND KIT THAT INCLUDES A COMBINATION OF PROGESTINE AND STROGEN. |
-
2006
- 2006-02-15 KR KR1020077016400A patent/KR20070087141A/en active IP Right Grant
- 2006-02-15 WO PCT/EP2006/001358 patent/WO2006087177A2/en active Application Filing
- 2006-02-15 PL PL06706961T patent/PL1848406T3/en unknown
- 2006-02-15 EP EP06706961A patent/EP1848406B1/en active Active
- 2006-02-15 BR BRPI0606297-0A patent/BRPI0606297A2/en not_active Application Discontinuation
- 2006-02-15 PT PT06706961T patent/PT1848406E/en unknown
- 2006-02-15 AU AU2006215822A patent/AU2006215822B2/en not_active Ceased
- 2006-02-15 AT AT06706961T patent/ATE395047T1/en active
- 2006-02-15 CA CA002594939A patent/CA2594939A1/en not_active Abandoned
- 2006-02-15 DK DK06706961T patent/DK1848406T3/en active
- 2006-02-15 JP JP2007551647A patent/JP2008527019A/en not_active Withdrawn
- 2006-02-15 ES ES06706961T patent/ES2310907T3/en active Active
- 2006-02-15 EA EA200701389A patent/EA200701389A1/en unknown
- 2006-02-15 DE DE502006000771T patent/DE502006000771D1/en active Active
- 2006-02-15 SI SI200630062T patent/SI1848406T1/en unknown
- 2006-02-15 RS RSP-2008/0358A patent/RS50597B/en unknown
-
2007
- 2007-06-06 NO NO20072893A patent/NO20072893L/en not_active Application Discontinuation
- 2007-06-27 IL IL184257A patent/IL184257A0/en unknown
-
2008
- 2008-08-13 HR HR20080394T patent/HRP20080394T3/en unknown
- 2008-08-14 CY CY20081100871T patent/CY1108265T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL1848406T3 (en) | 2009-06-30 |
ATE395047T1 (en) | 2008-05-15 |
KR20070087141A (en) | 2007-08-27 |
EP1848406B1 (en) | 2008-05-14 |
PT1848406E (en) | 2008-08-21 |
BRPI0606297A2 (en) | 2009-06-09 |
IL184257A0 (en) | 2007-10-31 |
RS50597B (en) | 2010-05-07 |
JP2008527019A (en) | 2008-07-24 |
ES2310907T3 (en) | 2009-01-16 |
EA200701389A1 (en) | 2008-02-28 |
WO2006087177A2 (en) | 2006-08-24 |
NO20072893L (en) | 2007-09-12 |
AU2006215822B2 (en) | 2008-09-04 |
WO2006087177A3 (en) | 2007-08-30 |
EP1848406A2 (en) | 2007-10-31 |
WO2006087177B1 (en) | 2007-10-11 |
CY1108265T1 (en) | 2014-02-12 |
WO2006087177A8 (en) | 2007-05-24 |
AU2006215822A1 (en) | 2006-08-24 |
CA2594939A1 (en) | 2006-08-24 |
SI1848406T1 (en) | 2008-10-31 |
DE502006000771D1 (en) | 2008-06-26 |
DK1848406T3 (en) | 2008-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20070188B1 (en) | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive | |
JP2007535519A5 (en) | ||
MX2008011074A (en) | Extended cycle multiphasic oral contraceptive method. | |
RS50972B (en) | Pharmaceutical composition containing gestagens and/or estrogens and 5-methyl-(6s)-tetrahydrofolate | |
EA200900491A1 (en) | USE OF ESTRADIOL VALERAT OR 17B-ESTRADIOL IN COMBINATION WITH DIENOGEST FOR ORAL TREATMENT TO MAINTAIN AND / OR INCREASE SEXUAL TREATMENT IN THE SPECIAL WOMAN | |
NO327588B1 (en) | Pharmaceutical composition and composition comprising ethinylostradiol and drospirenone for use as a contraceptive | |
HRP20080394T3 (en) | Peroral solid dosage form for contraception comprising dienogest and ethinylestradiol | |
TW200638951A (en) | Solid oral pharmaceutical form for contraception | |
UA85003C2 (en) | Solid peroral contraceptive drug | |
WO2008017331A3 (en) | Peroral drug form comprising dienogest and ethinyl estradiol for contraception | |
TH80558B (en) | Solid oral dosage forms for birth control | |
SI1937274T1 (en) | Use of estradiol valerate combined with dienogest for oral therapy of dysfunctional uterine bleeding in the form of oral contraceptives | |
TH80558A (en) | Solid oral dosage forms for birth control | |
JO2213B1 (en) | A pharmaceutical composition for use as a contraceptive | |
HRP20020666B1 (en) | Drospirenone for hormone replacement therapy | |
ECSP003721A (en) | A PHARMACEUTICAL COMPOSITION TO BE USED AS AN CONTRACEPTIVE |